Search by Drug Name or NDC
NDC 43063-0981-06 BENZONATATE 100 mg/1 Details
BENZONATATE 100 mg/1
BENZONATATE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is BENZONATATE.
MedlinePlus Drug Summary
Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.
Related Packages: 43063-0981-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Benzonatate
Product Information
NDC | 43063-0981 |
---|---|
Product ID | 43063-981_dc8f6090-a224-828c-e053-2a95a90af023 |
Associated GPIs | 43102010000105 |
GCN Sequence Number | 004641 |
GCN Sequence Number Description | benzonatate CAPSULE 100 MG ORAL |
HIC3 | H6C |
HIC3 Description | ANTITUSSIVES, NON-OPIOID |
GCN | 29840 |
HICL Sequence Number | 001929 |
HICL Sequence Number Description | BENZONATATE |
Brand/Generic | Generic |
Proprietary Name | BENZONATATE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | BENZONATATE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 100 |
Active Ingredient Units | mg/1 |
Substance Name | BENZONATATE |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Pharmaceutical Class | Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA040682 |
Listing Certified Through | 2023-12-31 |
Package
NDC 43063-0981-06 (43063098106)
NDC Package Code | 43063-981-06 |
---|---|
Billing NDC | 43063098106 |
Package | 6 CAPSULE in 1 BOTTLE, PLASTIC (43063-981-06) |
Marketing Start Date | 2020-02-19 |
NDC Exclude Flag | N |
Pricing Information | N/A |